Invanz and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Invanz (ertapenem sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Prilosec, and have Osteoporosis.

The phase IV clinical study analyzes which people have Cellulitis when taking Invanz. It is created by eHealthMe based on reports of 3,924 people who have side effects when taking Invanz from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,082 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 19, 2026

3,924 people reported to have side effects when taking Invanz.
Among them, 71 people (1.81%) have Cellulitis.

Among these 71 people:

How long have people been on Invanz when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Invanz? *

female: 62.86 %
male: 37.14 %

What is the age of people who have Cellulitis when taking Invanz? *

What are other drugs people take besides Invanz? *

What are other side effects people have besides Cellulitis? *

Pain: 55 people, 77.46%
Pain In Jaw: 50 people, 70.42%
Sinusitis (inflammation of sinus): 49 people, 69.01%
Spinal Osteoarthritis (joint cartilage loss in spine): 48 people, 67.61%
Exostosis (formation of new bone on the surface of a bone): 48 people, 67.61%
Bone Disorder: 47 people, 66.20%
Bone Fragmentation: 47 people, 66.20%
Dental Caries: 47 people, 66.20%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 47 people, 66.20%
Mouth Ulcers: 47 people, 66.20%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 29 people, 40.85%
Osteoporosis (bones weak and more likely to break): 29 people, 40.85%
Trismus (reduced opening of the jaws): 18 people, 25.35%
Multiple Myeloma (cancer of the plasma cells): 18 people, 25.35%
Thrombocytopenia (decrease of platelets in blood): 11 people, 15.49%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 8.45%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 5.63%
Oedema (fluid collection in tissue): 4 people, 5.63%
Neuropathy Peripheral (surface nerve damage): 4 people, 5.63%
Stress And Anxiety: 4 people, 5.63%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invanz:

Invanz (3,961 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,082 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium (the active ingredients of Invanz) and Invanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.